🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The standard anesthetic care plan for people having adolescent idiopathic s...
Status
Completed
Location
UF Health
Start Date
2015-11
Trial ID
NCT02481570
Treatments Being Tested
Microgravity during space flight induces physiological changes that affect ...
Status
Completed
Location
Medes-Imps
Start Date
2001-08
Trial ID
NCT00311571
Treatments Being Tested
Dosing of tacrolimus is challenging due to the large inter-individual varia...
Status
Completed
Location
Olso university hospital - Rikshospitalet
Start Date
2014-01
Trial ID
NCT02010320
Treatments Being Tested
Several population pharmacokinetic (PK) models for cefepime in critically i...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02680600
Nowadays the association between radiotherapy and the anti- Epidermal Growt...
Status
Unknown
Location
Division of Radiotherapy European Institute of Oncology
Start Date
2014-01
Trial ID
NCT03001570
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics of dapivirine...
Status
Completed
Location
University of Pittsburgh CRS
Start Date
2018-05-10
Trial ID
NCT03393468
Treatments Being Tested
This study will assess and characterize the variability observed in the res...
Status
Completed
Location
Cliniques universitaires Saint-Luc
Start Date
2017-03-23
Trial ID
NCT03101644
Treatments Being Tested
This is a double-blinded, randomized, pharmacokinetic and safety study of 3...
Status
Completed
Location
Johns Hopkins University, Division of Clinical Pharmacology, Drug Development Unit
Start Date
2013-03
Trial ID
NCT01575418
Urinary tract infections (UTIs) are the leading cause of community-acquired...
Status
Terminated
Location
Rouen University Hospital
Start Date
2024-09-30
Trial ID
NCT07169097
Treatments Being Tested
A subcutaneous formulation of infliximab CT-P13 (Remsima, Celltrion) has be...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07120152
Treatments Being Tested